AMPH
HEALTHCAREAmphastar Pharmaceuticals Inc
$23.90+0.51 (+2.18%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AMPH Today?
No stock-specific AI insight has been generated for AMPH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$17.03$31.26
$23.90
Fundamentals
Market Cap$1.1B
P/E Ratio11.8
EPS$2.03
Dividend Yield—
Dividend / Share—
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume393K
Avg Volume (10D)—
Shares Outstanding44.5M
AMPH News
21 articles- Amphastar Pharmaceuticals (AMPH) Is Up 9.4% After Profit Falls Despite New Drug Launches And Licensing DealsYahoo Finance·May 9, 2026
- Amphastar Pharmaceuticals, Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- Amphastar (AMPH) Q1 2026 Earnings TranscriptMotley Fool·May 8, 2026
- Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key MetricsYahoo Finance·May 8, 2026
- Amphastar Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag EstimatesYahoo Finance·May 7, 2026
- Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock DropsYahoo Finance·May 7, 2026
- Amphastar: Q1 Earnings SnapshotKING5.com·May 7, 2026
- Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026Yahoo Finance·May 7, 2026
- Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care ConferenceYahoo Finance·May 6, 2026
- Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue EstimatesYahoo Finance·May 5, 2026
- 1 Cash-Producing Stock for Long-Term Investors and 2 We Turn DownYahoo Finance·May 5, 2026
- Jefferies Downgrades Amphastar Pharmaceuticals (AMPH), Cites Lack of Meaningful Upside CatalystsYahoo Finance·May 1, 2026
- Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026Yahoo Finance·Apr 30, 2026
- AMPH vs. RDY: Which Stock Should Value Investors Buy Now?Yahoo Finance·Apr 29, 2026
- Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·Apr 29, 2026
- Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?Yahoo Finance·Apr 29, 2026
- Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding TodayYahoo Finance·Apr 21, 2026
- Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings?Yahoo Finance·Apr 21, 2026
- Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To KnowYahoo Finance·Apr 18, 2026
- 1 Healthcare Stock to Target This Week and 2 We AvoidYahoo Finance·Apr 16, 2026
All 21 articles loaded
Price Data
Open$23.50
Previous Close$23.39
Day High$24.15
Day Low$23.50
52 Week High$31.26
52 Week Low$17.03
52-Week Range
$17.03$31.26
$23.90
Fundamentals
Market Cap$1.1B
P/E Ratio11.8
EPS$2.03
Dividend Yield—
Dividend / Share—
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume393K
Avg Volume (10D)—
Shares Outstanding44.5M
About Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—